| Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en … JM Ribera, A Oriol, MA Sanz, M Tormo, P Fernández-Abellán, E del Potro, ... Journal of Clinical Oncology 26 (11), 1843-1849, 2008 | 320 | 2008 |
| Treatment of high-risk Philadelphia chromosome–negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual … JM Ribera, A Oriol, M Morgades, P Montesinos, J Sarra, ... Journal of Clinical Oncology 32 (15), 1595-1604, 2014 | 299 | 2014 |
| Risk factors and outcome of COVID-19 in patients with hematological malignancies JL Piñana, R Martino, I García-García, R Parody, MD Morales, G Benzo, ... Experimental Hematology & Oncology 9, 1-16, 2020 | 147 | 2020 |
| Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia CM Santamaría, MC Chillón, R García-Sanz, C Perez, MD Caballero, ... Blood, The Journal of the American Society of Hematology 114 (1), 148-152, 2009 | 134 | 2009 |
| Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome M Constans, A Sureda, MJ Terol, R Arranz, MD Caballero, A Iriondo, ... Annals of oncology 14 (5), 745-751, 2003 | 72 | 2003 |
| Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of … A Oriol, JM Ribera, J Esteve, MA Sanz, S Brunet, R Garcia-Boyero, ... haematologica 88 (4), 445-453, 2003 | 70 | 2003 |
| High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics CM Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ... Leukemia research 33 (12), 1706-1709, 2009 | 69 | 2009 |
| A prognostic model for survival after salvage treatment with FLAG‐Ida+/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia JM Bergua, P Montesinos, D Martinez‐Cuadrón, P Fernández‐Abellán, ... British Journal of Haematology 174 (5), 700-710, 2016 | 62 | 2016 |
| Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia B Sanchez-Gonzalez, JC Pascual-Ramirez, P Fernandez-Abellan, ... Blood, The Journal of the American Society of Hematology 101 (6), 2446-2446, 2003 | 54 | 2003 |
| Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia MB Vidriales, E Pérez-López, C Pegenaute, M Castellanos, JJ Pérez, ... Leukemia research 40, 1-9, 2016 | 48 | 2016 |
| Post-transplant Burkit t's Leukemia or Lymphoma. Study of Five Cases Treated with Specific Intensive Therapy (PETHEMA ALL-3/97 Trial) B Xicoy, JM Ribera, J Esteve, S Brunet, MA Sanz, P Fernández-Abellán, ... Leukemia & lymphoma 44 (9), 1541-1543, 2003 | 37 | 2003 |
| Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols C Motlló, JM Ribera, M Morgades, I Granada, P Montesinos, ... Cancer 120 (24), 3958-3964, 2014 | 30 | 2014 |
| Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003–2017) C López-Menchero, M Alvarez, P Fernández, M Guzmán, ... Blood transfusion 17 (6), 418, 2019 | 23 | 2019 |
| Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective … JM Ribera, O García, P Fernández-Abellán, E Lavilla, MT Bernal, ... British journal of haematology 159 (4), 2012 | 21 | 2012 |
| Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study MJ Cejalvo, M Legarda, E Abella, E Cabezudo, C Encinas, A García-Feria, ... British journal of haematology 190 (5), e289-e292, 2020 | 18 | 2020 |
| Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study M Chumbita, P Puerta-Alcalde, L Yáñez, MA Cuesta, A Chinea, ... Journal of Antimicrobial Chemotherapy 77 (7), 2017-2023, 2022 | 15 | 2022 |
| Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study JM Sancho, M Morgades, R Arranz, P Fernández-Abellán, G Deben, ... Medicina clínica 131 (11), 401-405, 2008 | 15 | 2008 |
| Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis JM Sancho, G Deben, A Parker, JL Piñana, S Bolam, E Sánchez-García, ... International journal of hematology 86, 33-36, 2007 | 14 | 2007 |
| Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD … JM Ribera, A Oriol, M Morgades, MA Sanz, P Montesinos, J Sarra, ... Blood 114 (22), 322, 2009 | 13 | 2009 |
| High rate of inappropriate antibiotics in patients with hematologic malignancies and Pseudomonas aeruginosa bacteremia following international guideline recommendations M Chumbita, P Puerta-Alcalde, L Yáñez, M Angeles Cuesta, A Chinea, ... Microbiology Spectrum 11 (4), e00674-23, 2023 | 10 | 2023 |
